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Abstract
Background: Only 29 cases of constitutional 9q22 deletions have been published and all have been sporadic.
Most associate with Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS, MIM #109400) due to
haploinsufficiency of the PTCH1 gene (MIM *601309).
Methods and Results: We report two mentally retarded female siblings and their cognitively normal father, all
carrying a similar 5.3 Mb microdeletion at 9q22.2q22.32, detected by array CGH (244 K). The deletion does not
involve the PTCH1 gene, but instead 30 other gene,s including the ROR2 gene (MIM *602337) which causing both
brachydactyly type 1 (MIM #113000) and Robinow syndrome (MIM #268310), and the immunologically active SYK
gene (MIM *600085). The deletion in the father was de novo and FISH analysis of blood lymphocytes did not
suggest mosaicism. All three patients share similar mild dysmorphic features with downslanting palpebral fissures,
narrow, high bridged nose with small nares, long, deeply grooved philtrum, ears with broad helix and uplifted
lobuli, and small toenails. All have significant dysarthria and suffer from continuous middle ear and upper
respiratory infections. The father also has a funnel chest and unilateral hypoplastic kidney but the daughters have
no malformations.
Conclusions: This is the first report of a familial constitutional 9q22 deletion and the first deletion studied by array-
CGH which does not involve the PTCH1 gene. The phenotype and penetrance are variable and the deletion found
in the cognitively normal normal father poses a challenge in genetic counseling.
Background
The first constitutional deletion of 9q22 was published
in 1978 by Turleau [1] and since then only 29 patients
have been reported, including two terminated fetuses.
All have been sporadic (Table 1). In recent years, array
comparative genomic hybridization (array CGH) has
enabled more detailed reports on the genetic basis of
9q22 deletions. Reported deletion sizes vary from 2.3
Mb to more than 18 Mb and no recurrent breakpoints
have been observed (Table 1). While most reported
deletions are sporadic, three balanced parental chromo-
somal rearrangements involving 9q have been detected
and two of these have likely predisposed to the deletion
in the descendants [2,3] while one deletion lies outside
the parental rearrangement [4]. Parental origin of the
deleted chromosome has been traced in eleven cases of
which eight were paternal [2 (patient 3), 3 (patient 1),
5-8,] and three maternal [3 (patient 2), 9, 10] (Table 1).
Characteristic to all these deletions are non-recurrent
breakpoints leading to variable gene composition and an
inconsistent phenotype. Most of them, however, span
the PTCH1 gene (MIM *601309) and associate with
G o r l i ns y n d r o m eo rn e v o i db a s a lc e l lc a r c i n o m a
(NBCCS, MIM #109400) due to haploinsufficiency of
PTCH1.
W ed e s c r i b eaf a m i l yw h e r et w om e n t a l l yr e t a r d e d
siblings and their cognitively normal father share an
identical 5,3 Mb deletion at 9q22.2q22.32, not including
PTCH1, and discuss genotype-phenotype correlation in
these patients.
Methods
Cytogenetic analysis
Chromosome metaphase spreads of patients 1, 3, and
the healthy mother were analyzed by standard G-band-
ing karyotype analysis (400 band resolution). Additional
subtelomere-fluoresence in situ hybridization (FISH)
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reproduction in any medium, provided the original work is properly cited.Table 1 Summary of clinical and molecular features of previously reported patients with constitutional 9q22 deletions and the present ones.
Reference Patient’s
age and
gender
Postnatal
height
Postnatal
OFC
CNS features Malformations Dysmorphic features Clinical Gorlin
syndrome
Method of
detection
Locus of the
deletion
Parental origin
and/or
Parental
chromosomal
rearrangement
Size of
deletion
PTCH1 ROR2
[28] 1y11m
male
+ 3,8SD > p 90 global delay
hypotonia
no falx calcification
right hydronephrosis
left multicystic kidney
left hand preaxial
polydactyly
hypertelorism
frontal bossing
epicanthi
low nasal bridge
low-set ears
auricular pits
long philtrum
high palate
short, webbed neck
sacral dimple
with reservations to
young age
aCGH (Agilent
180 chip) and
FISH
9q22.3 de
novo
2,44 Mb deleted nr
[14] 2 y 3 m
male
> p97 p75-97 moderate MR,
wide cranial sutures,
open posterior
fontanelle
submucous cleft
palate,
pectus excavatum
epicanthic folds,
wide and short neck,
low nuchal hairline,
wide nasal bridge,
low-set and posteriorly
rotated ears,
micrognathia, widely
spaced nipples,
small teeth,
deep plantar grooves
with reservations to
young age
aCGH at 1 Mb
resolution
9q22.32q31.1
de novo
6,54-8,12
Mb
deleted nr
[5] 3 y 9 m
female
+2,2SD +3,5SD normal development,
hypotonia, spasticity,
cleft lip-palate,
pigmented cyst on
shoulder (ectopic
meninx)
ASD
frontal bossing
epicanthic folds, broad
eyebrows, synophrys,
c-a-l spot on legs and arm
yes
palmar & plantar
pits
aCGH (Agilent
105A chip)
9q22.32 de
novo
paternal 2.3 Mb deleted nr
[26, patient 1] 12 y male -1,1SD +1,7SD moderate MR,
seizures/epilepsy
epicanthi
mouth small
upper lip thin
strabismus
yes
falx calcification,
frontal
ganglioglioma, rib
anomalies,
odontogenic
ceratocysts, palmar
and plantar pits
FISH with BAC
clones
9q21.33q22.33
de novo
15,33-
16,04 Mb
deleted nr
[26, patient 2] 23 y male +1,9SD +2,6SD severe MR, seizures,
trigonocephaly,
craniosynostosis,
cleft lip-palate
retinal detachement,
cataract, glaucoma
double urethra
hypertelorism yes
odonto-genic
ceratocysts,
thyroid
adenocarcinoma
FISH with BAC
clones
9q21.33q31.1
de novo
18,08-
18,54 Mb
deleted nr
[27, restudy
of patient 1
originally
presented
in 33]
50 y
female
normal macrocephaly mild MR,
hypotonia,
“rib and bone
anomalies”
kidney problems, one
eye blind
frontal bossing,
palpebral fissures slant down,
epicanthi,
maxillary prognatism,,
dense eyebrows,
dental anomalies,
delayed dental eruption
yes
basocellular
carcinomas,
jaw cysts,
intracranial
calcification,
palmoplantar pits
quantitative
multiplex
fluorescent PCR,
polymorphic
markers, long-
range PCR,
sequencing
9q22.32q22.33
de novo
4,5 Mb deleted nr
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4Table 1 Summary of clinical and molecular features of previously reported patients with constitutional 9q22 deletions and the present ones. (Continued)
[25, patient
G10]
8 y male nr nr severe MR,
epilepsy, hydrocephalus
inguinal hernia,
polydactyly
scoliosis
hypertelorism yes
palmar & plantar
pits
HR microarray inv(9)
(q21.2q33.1) =
9q22.32
92,934,973/
92,945,040-
98,137,216/
98,141,889
5 Mb deleted nr
[16, patient G5,
restudy of
patient
originally
presented in 34]
12 y male nr >p97 severe MR, epilepsy,
dilated lateral ventricles,
thin corpus callosum,
hydrocephalus
hydronephrosis,
scoliosis
hypertelorism
epicanthi
webbed neck
yes
basal cell
carcinoma,
palmar and plantar
pits,
multiple jaw cysts
odonto-genic
ceratocysts,
calcification of falx
and tentorium
cerebelli
HR microarray 9q21.31q22.31
de novo
88,656,506/
88,656,835-
99,686,554/
99,687,352
11 Mb deleted deleted
[17] 12 y
female
nr normal severe MR, brain
atrophy
laryngeal stenosis,
pulmonary valve
stenosi, pectus
excavatum,
kyphoscoliosis,
hypoplastic clavicles
down-slanting palpebral fissures,
epicanthi, prognatism,
asymmetric palpebral fissures,
broad eyebrows,
synophrys
high forehead,
pointed chin
short neck,
c-a-l-spots
yes aCGH 9q22.1q22.32
de novo
7,7 Mb deleted deleted
[6] 13 y
female
nr nr MR,
ventriculomegaly
mild macroglossia hypertelosim,
frontal bossing,
epicanthi,
ears posteriorly rotated,
teeth small,
prominent gingivae,
toenails hypoplastic,
mild hemihypertrophy
yes
mandibular cysts,
plantar and palmar
spots,
rhabdomyosarcoma,
Wilms tumor
karyotype,
polymorphic
markers at the
PTCH1 region
9q22q32 de
novo
paternal nr deleted nr
[7, patient 1] 5 y male +2,5SD +2SD severe MR umbilical hernia,
pectus excavatum,
trigonocephaly-
craniosynostosis
epicanthi
mouth small
upper lip thin
ear pits
ears low set
ear lobules uplifted hyperlaxity,
short neck,
with reservations to
young age
aCGH at 1 Mb
resolution
9q22.32q22.33
de novo
paternal < 6,5 Mb not
tested
nr
[7, patient 2] 8 y
female
+2SD >+3SD severe MR, seizures
trigonocephaly
ventriculomegaly
thin corpus callosum
thyroglossal cyst with
sternal fistula,
no dentition,
umbilical hernia,
pectus excavatum,
kyphosis
epicanthi,
palpebral fissures slant down,
small mouth,
thin upper lip,
thick ears
indentation of ear lobules.
short neck
with reservations to
young age
aCGH at 1 Mb
resolution
9q22.32q22.33
de novo
paternal < 6,5 Mb not
tested
nr
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4Table 1 Summary of clinical and molecular features of previously reported patients with constitutional 9q22 deletions and the present ones. (Continued)
[27] 5 m male p75-90 p90-97 MR, hypotonia
seizures
hydfrocephalus caused
by compression by
cerebellar vermis
inguinal hernias,
PDA,
undescended testes,
high arched palate,
postaxial polydactyly
of left foot,
cervical ribs
hypertelorism, prognatism,
broad face and
forehead, broad
nasal bridge,
supraorbital ridges well developed
yes HR karyotype,
aCGH, FISH
9q22.32q31.3
de novo
paternal 12 Mb deleted nr
[15] 21 y male +0,2SD -1SD mild MR kyphosis, postaxial
polydactyly,
mild pulmonary valve
stenosis, inguinal
hernias, undescended
testes, hypodontia of
permanent teeth,
palate high arched,
uvula bifid, bilateral
nasal stenosis,
taurodonty of 2
nd
molars
frontal bossing
epicanthi,
palperbral fissures slant down,
prognatism, synophrys, hypotelorism,
excess nuchal skin,
ears low-set and posteriorly rotated,
nares anteverted,
lips thick,
face high
yes
calcification of cella
turgica and falx
cerebri, basal cell
nevus carcinomas,
jaw cysts
HR karyotype,
FISH with BAC
clones
9q21.3q31 de
novo
15.3-15.6
MB
deleted deleted
[32] 29 y
female
short nr poor vision,
telangiectatic nodule
on skin
hemivertebra T5,
scoliosis,
elongated clavicle
hypotelorism,
ulnar deviation of hands
yes
multiple basaliomas,
calcification of falx,
tentorium cerebri
and cella turcica,
mandibular cysts
karyotype 9q22.1q31.2 parents not
available
nr assumed
deleted
nr
[4] 12 y
female
nr nr mild MR,
bridging of cella turcica,
broad cavum septi
pellucid, dilated cerebral
ventricles
hyperopia,
deverticulum of the
renal calyx, occult
spina bifida L5-S4,
pectus excavatum,
bilateral patellar
dysplasia, unsual
clavicles, exostosis of
distal phalanx of
thumb
thumbs, abnormal
hypoplasia of maxilla
hypertelorism, biparietal bossing,
epicanthi, palpebral fissures slant down,
prognatism, synophrys,
webbed neck,
synophrys and broad eyebrows,
low midface,
broad nose tip,
low set, posteriorly rotated ears
yes
basalioma
basal cell nevi
trichoepithelioma
HR karyotype,
FISH
9q22.32q33.2
de novo
outside the
maternal
translocation
familial t(9;17)
(q34.1p11.2)mat
nr deleted nr
[30, patient A] age nr,
female
nr nr MR nr karyotype,
aCGH
9q21q22.1 nr nr deleted
[30, patient B] age nr,
female
nr nr MR nr karyotype,
aCGH
9q22.1q31.2 nr nr deleted
[8] 6 y male p50 >p97 severe MR
hypotony
PDA, severe scoliosis,
fingers slender, 5
th
finger camptodactyly,
palate high arched,
short metacarpals and
distal phalanges
frontal bossing,
epicanthi,
palpebral fissures slant down,
ears low-set,
hypoplastic nostrils,
micrognarhia,
small nails
with reservations to
young age
increasing nr of
nevi,
sole pits
HR karyotype,
FISH,
genotyping
9q22.31q31.2
de novo
paternal D9S303
->D9S930
deleted deleted
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4Table 1 Summary of clinical and molecular features of previously reported patients with constitutional 9q22 deletions and the present ones. (Continued)
[3, patient 1] 15 y
female
<p3 p75 MR, hydrocephalus with
shunt, corpus callosum
agenesis
inguinal hernias,
bilateral conductive
hearing loss, ectopic
eruption of incisors,
occult spina bifida T2-
T3, scoliosis
frontal bossing, synophrys,
prognathism
yes
palmoplantar pits,
bifid ribs
HR karyotype,
RLFP
polymorphisms
9q22q22 de
novo
paternal 10-16 cM deleleted deleted
[3, patient 2] 26 y
female
short microcephaly MR PDA, CoA, anomalous
right subclavian artery,
bilat conductive
hearing loss
frontal bossing, hypertelorism,
prognatism, prominent supraorbital
ridges,
high palate
yes
multiple basal cell
carcinomas,
leiomyoma coli,
multiple bifid ribs
odontogenic
ceratocysts,
ameloblastoma
HR karyotype,
RLFP
polymorphisms
FISH
9q22q32 de
novo
maternal t(ins
[9]
[p22q32q22];16)
(p22;q21) mat
22-39 cM deleted deleted
[9] 14 y male <p3 <p3 severe MR
brachycephaly, dilated
ventricles
undescended testes,
left pes equinovarus,
I partial I-IV toe
syndactyly,
frontal bossing, hyperteloris,
epicanthi,
palpebral fissures slant down, broad
eyebrows, wide mouth, thick lips,
irregular dentition,
ears small, no ear lobes,
short neck, wide internipple distance,
hypoplastic genitalia,
tapering fingers, small toes, medial
deviation of toes
nr karyotype 9q22q32 de
novo
maternal nr nr nr
[21] 15 m
male
p25 p75 severe MR,
partial aplasia of corpus
callosum,
dilatation of ventricles
laryngomalacia,
cleft palate,
PDA, abnormal aortic
valve,
epiglottic dysplasia,
abnormal vocal cords
frontal bossing, palpebral fissures slant
down, hypertrichosis, long eyelashes,
epicanthus inversus,
nose short, brodge depressed, nares
upturned,
long philtrum,
small mouth, thin upper lip,
receding chin,
ears large and low set,
large lobules,
loose skin on cheeks
nr karyotype (500
bands)
9q22q2207 de
novo
nr nr nr
[2, patient 3] 7 m
female
p90 p75 mild to moderate MR,
brachycephaly,
hydrocephalus
VSD,
PDA hallux valgus
hypertelorism,epicanthi,
synophrys,
ptosis,
philtrum short ears posteriorly rotated
nr HR karyotype 9q22.3q31.1 de
novo
paternal dir ins
(4;9)(q33;
q22.3q31.1) pat
nr nr nr
[35] infant
male
nr nr asymmetric ventricles,
partial fusion of
cerebellar hemispheres,
polymicrogyria, delayed
cerebellar neuronal
migration, enlarged
massa intermedia
cryptorchidism, focal
glomerulosclerosis,
accessory spleen,
partial fusion of
vertebrae D2 and D3,
pectus excavatum,
irregular ribs
interphalangeal
ankylosis
nr karyotype 9q22q32 de
novo
nr nr nr
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4Table 1 Summary of clinical and molecular features of previously reported patients with constitutional 9q22 deletions and the present ones. (Continued)
[10] 3 m male nr nr death at 3 months,
seizures
duodenal atresia,
malrotation,
Meckel diverticulum,
multilobulated spleen,
accessory spleens
renal dysplasia,
hydroureter
polydactyly of hand,
syndactyly of feet
angulated clavicles
thorax asymmetric
palpebral fissures slant down, epicanthi,
hypotelorism, hirsutism, short palpebral,
fissures, depressed nasal bridge,
auditory canals narrow,
philtrum long
nr
unusual ribs,
karyotype, Q, C
and R bands
9q22q32 de
novo
maternal nr nr nr
[1, patient 1] 14 y male -1SD 0SD severe MR,
epilepsy
hypertelorism,
palpebral fissures slant down, nose
short, nares anteverted,
philtrum long, mild micrognathia
nr karyotype with
R bands
9q11q22 de
novo
nr nr nr
Present case 3 37 y male -1SD -0,25SD normal cognition,
dysarthria
grade IV
vesicoureteral reflux,
hydroureter and
hypoplastic left
kidney. funnel chest,
three lower-most
costal cartilages
broadly fused
deepset and small toenails, palpebral
fissures slant down, high bridged nose,
narrow nares, long deep furrowed
philtrum, ears with broad helices and
uplifted lobuli, short 2
nd finger nails
no aCGH 9q22.2q22.31
de novo
5,3Mb not
deleted
deleted
Present case 1 8,5 y
female
0,1SD +0,5SD moderate MR,
dysarthria
short neck, slight ptosis on the right,
downward slant of the palpebral
fissures, narrow nose, small nares, long
philtrum with a narrow deep groove,
tented upper lip, ears with broad helices
and uplifted lobuli. toe nails II-V
bilaterally small
no aCGH 9q22.2q22.31 paternal 5,3 Mb not
deleted
deleted
Present case 2 4 y
female
-0,2SD +1SD moderate MR,
dysarthria
down slanting palpebral fissures, mild
left side ptosis, narrow nares, uplifted
ear lobuli and thick helices, long
philtrum with a deep furrow, thin and
tented upper lip.
no aCGH 9q22.2q22.31 paternal 5,3Mb not
deleted
deleted
All values given as reported in each original paper.
Abbreviations: nr = no report, y = year, m = month, OFC = head circumference; CNS = central nervous system; MR = mental retardation; p = percentile; SD = standard deviation, aCGH = array comparative genomic
hybridization, HR = high resolution.
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4analysis was conducted on patient 1 according to stan-
dard protocols. Targeted FISH-analysis of lymphocyte
c e l l so fp a t i e n t3w a sp e r f o r m e du s i n gB A C - p r o b e
RP11-30L4.
Molecular karyotyping
M e n t a lr e t a r d a t i o ni na d d i t i o nt os u b t l eb u tu n d i s p u t a -
ble dysmorphic features in patients 1 and 2 were indica-
tions to perform additional high-resolution analysis by
comparative genomic hybridization (CGH) and single
nucleotide polymorphism (SNP) arrays. Standard mole-
cular karyotyping was performed using a 244 K CGH
array (Agilent Technologies, Santa Clara, CA, USA), as
previously described [11].
Array CGH results were confirmed by SNP array ana-
lysis of patients 1 and 3 and the paternal grandparents,
using the Genome-Wide Human SNP array 6.0 accord-
ing to manufacturer instructions (Affymetrix, Santa
Clara, CA, USA). The SNP 6.0 array contains 906,000
SNP probes and 946,000 copy number probes and has
an average resolution of 0.7 kb. Data was extracted
using the Genotyping console software V.3.0.2 with
default settings, including the BRLMM-P-Plus algorithm
and the Hidden-Markow Model for smoothing the copy
number data. As a reference set we used data from 90
Caucasian HapMap samples. The extracted data was
further analyzed using the Chromosome Analysis Suite
software V.1.0. Copy number changes were called and
filtered based on reference data and a minimum amount
of 10 consecutive probes. All changes that were called
were further compared to the Database of Genomic
Variants (DGV, http://projects.tcag.ca/variation) as well
as in-house data (unpublished material). All array data
is stored in and available from the CanGEM Database
(http://www.cangem.org). Array CGH and SNP data
were analyzed using the reference genome build 18
(NCBI 36).
Clinical report
The family has four children and in addition the mother
has a history of four first trimester miscarriages. Patients
1a n d2a r et h e2
nd and 3
rd b o r nc h i l d r e ni nt h ef a m i l y .
The psychomotor development of the eldest daughter
has been within normal limits, but she suffers from
short attention span and need special support at school.
The youngest boy is considered healthy at 10 months of
age. The paternal grandparents have neither learning
problems nor congenital abnormalities and the family
history is unremarkable (Figure 1).
Patient 1, a girl, was born after an uneventful preg-
nancy. She had normal birth size (3450 g, 49 cm, OFC
3 5c m )a n dA p g a rs c o r ew a s1 0a t1a n d5m i n u t e s .A
drop in blood hemoglobin from 172 g/l to 127 g/l was
observed during the first day and she received a red cell
transfusion. No evidence for bleeding, infection,
hemoglobin abnormality, or immunization were found.
She was discharged in good condition at the age of one
week. She has suffered from recurrent middle ear infec-
tions since 1 year of age and repeated insertion of grom-
mets and prophylactic antibiotics were not helpful. She
Figure 1 Pedigree of the family Patients 1, 2, and 3 all have the deletion of 9q22, as indicated by the star. The healthy mother, sister, and
paternal grandparents, do not have the deletion, as indicated by N. The healthy brother was not tested for the deletion. Only patients 1 and 2
(P1, P2) have mental retardation.
Siggberg et al. Orphanet Journal of Rare Diseases 2011, 6:45
http://www.ojrd.com/content/6/1/45
Page 7 of 14developed bronchial asthma at the age of four years. At
2 and 3 years she had febrile convulsions but EEG
recordings were normal.
She learned to walk independently at 20 months and
spoke her first words at 15 months. At 4 years neurop-
sychological examination showed mild mental retarda-
tion, defective linguistic development and clumsy fine
motor performance. At 9 years she attends a school for
developmentally handicapped children and has learned
elements of reading and writing. She needs help in basic
daily skills. She speaks using sentences, but her speech
is dysarthric. The vicious circle of ear infections
continues. She needs treatment for asthma and uses
melatonin for sleep problems.
During the first two years her height was at +2SD and
has thereafter approached +0.5SD (target height -0.5SD).
She has overweight (BMI 24) since 2 years of age. The
OFC grows steadily at -0.5SD. She has normal body
proportions, short neck, slight ptosis on the right,
downward slant of the palpebral fissures, narrow nose,
small nares, long philtrum with a narrow deep groove,
tented upper lip, ears with broad helices and uplifted
lobuli. Her toe nails II-V are small on both feet; other-
wise feet, toes, hands, fingers and fingernails are normal
(Figures 2 and 3).
Blood lymphocyte counts have repeatedly been nor-
mal. She has normal immunoglobulin levels including
IgG subclasses, C3 and C4 and alpha-1-antitrypsin and
no IgE related allergies have been found. Urine meta-
bolic screen was negative an no vacuolated lymphocytes
were detected. The brain MRI and US of kidneys and
abdominal organs were normal at the age of 4.5 years.
X-rays of the thorax showed no skeletal anomalies.
Chromosome analysis (400 bands), subtelomere-FISH,
22q11 FISH (TUPLE1 probe), and FRAXA mutation
analysis were normal.
Patient 2 is the younger sister of patient 1. She was
born at term after an uneventful pregnancy. The mother
Figure 2 Facial features of the patients Facial features of patients 1 to 3 from left to right. Note short neck, slight unilateral ptosis, downward
slant of the palpebral fissures, narrow nose, small nares, long philtrum with a narrow deep groove, tented upper lip, ears with broad helices and
uplifted lobuli.
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Page 8 of 14was treated with acyclovir for herpes simplex type1
infection from the 17
th week up until the delivery and
with hydroxysitsin for her itching. Her birth size was
normal (3770 g, 52 cm, OFC 35 cm) At the age of three
weeks she was admitted to hospital for apneas caused
by pulmonary and middle ear infections and needed
mechanical ventilation for four days. The causative
microorganism was not identified. EEG recording
showed right sided spikes and phenobarbital treatment
was started. At 6 months the medication was discontin-
ued due to absence of epileptic symptoms and normal
EEG. Brain MRI, cardiac conduction examinations, and
cardiac ultrasound were normal.
Psychomotor developmental delay was obvious since
the age of 6 months. She learned to walk independently
at 2.5 years, spoke words at 3 years and short sentences
at 5 years of age. At 5 years her speech is dysarthric, she
has problems of falling asleep in the evening and treat-
ment with melatonin has shown modest success. She has
sudden attacks of aggression and abrupt standstills when
she is withdrawn from contact and stares or cries and
holds her head between her hands. EEG recordings show
no epileptic activity. Her ability of reciprocal contact is
very defective. She also suffers from abundant ear infec-
tions and from a tendency to asthmatic bronchitis. Dur-
ing the 1
st year her height increased from +1SD to +2SD
and then has declined to -0,5SD (her target height). Her
OFC has grown at 0SD during the first 6 months of life
and thereafter has remained at +1SD. She shows down
slanting palpebral fissures, mild left side ptosis, narrow
nares, uplifted ear lobuli and thick helices, long philtrum
with a deep furrow, thin and tented upper lip (Figures 2
and 3). Her immunoglobulin levels are normal, but IgE
related food allergy has been suspected.
Patient 3 is the father of patients 1 and 2. He was
born term after a normal pregnancy. His birth size was
normal (53 cm, 4090 g) and Apgar score was 9 at 1 and
10 at 5 minutes. At the age of 2.5 months he had a feb-
rile pyelonephritis and urological examinations revealed
grade IV vesicoureteral reflux, hydroureter and hypo-
plastic left kidney. In adult age his renal function has
been normal. He suffered from recurrent middle ear
infections and secretory otitis up to his teens. Surgery to
correct his funnel chest was attempted when he was 6
years old. The surgery report describes the three lower-
most costal cartilages being broadly fused. The
Figure 3 Hands and feet of the patients Hands and feet of patients 1 to 3 from left to right. Note that patient 1 has small toe nails II-V on
both feet and patient 3 has small and deep-set toenails and his 2
nd finger nails are short.
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Page 9 of 14immediate postoperative X-ray could be traced and it
showed normal claviculae, ribs and thoracic vertebrae.
His psychomotor development during childhood was
considered normal except speech development and he
had speech therapy up to his teens. At adult age he still
suffers from dysarthria. His school and military service
history are unremarkable. Presently he works as a mail-
man and studies to become a nurse’s aide.
At 1 year of age his height was 80 cm (+1SD). His adult
height is 171,5 cm (-1SD), weight 68 kg (BMI 23) and
OFC 57 cm (-0,8SD). He has partial upper denture after
removal of decayed front teeth. The thoracic cage shows
sequelae of childhood surgery and the sternum appears
short but body-limb proportions are normal. He has
down-slanting palpebral fissures, high nasal bridge, narrow
nares, long philtrum with deep furrow, and the ears have
broad helices and uplifted lobule. The 2nd finger nails are
short and he has deep set toe nails. (Figures 2 and 3).
Results
Karyotype analysis of patients 1, 3, and the mother, were
normal. Sub-telomere FISH analysis of patient 1 was
also normal.
Both array CGH and SNP array analysis revealed an
identical 5.3 Mb deletion of chromosome 9q22.2q22.32 in
all three patients, ranging from basepair 91,523,558
to 96,858,929 (Agilent probes A_16P18688441-A_16_
P02135862), covering 30 genes (Figure 4). The average
log2-ratio was -1, indicating a one-copy deletion.
The parents of patient 3 and the older sister of
patients 1 and 2 were studied for the microdeletion with
normal results. Targeted FISH-analysis of at least 80
metaphase spreads, using BAC-probe RP11-30L4, was
c o n d u c t e di na ne f f o r tt od e t e c tm o s a i c i s m9 q 2 2i n
patient 3. All metaphases showed the deletion of 9q22.
Although these results do not exclude germline mosai-
cism of patient 3, the likelihood is small.
Discussion
The clinical and molecular findings of the previously
reported 27 live patients and our 3 patients with constitu-
tional 9q22 deletions are summarized in Table 1. Two pre-
natally terminated fetuses are not included in the analysis
[12,13]. Based on available breakpoint information, at least
eight reported patients have an overlapping deletion with
the one detected in this family (Figure 5) [5,7,14-17].
Figure 4 Array CGH results revealed a deletion at 9q22 in all three patients Array CGH results of patients 1, 2 and 3 revealed a 5.3 Mb
deletion in all patients at 9q22.2q22.32. The shaded area indicates the deleted area with an average log2-ration of -1, indicating loss of one
copy of the genomic segment.
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PTCH1 gene intact. Instead, according to DECIPHER
database (the DECIPHER consortium, http://decipher.
sanger.ac.uk/), three genes in the deleted area, viz. SYK,
IARS and ASPN, are scored as likely haploinsufficient
[18]. SYK is involved in several important biological pro-
cesses as discussed below. An allelic variant of ASPN
has been implicated in osteoarthritis [19] and lumbar
disc degeneration [20]. Neither of these features was
present in our patients. IARS encodes an isoleucyl-tRNA
synthetase protein and deletions of this gene have not
been associated with human disease. In addition, three
clustered micro-RNAs (miRNA) called hsa-let-7a, hsa-
l e t - 7 fa n dh s a - l e t - 7 da r ef o u n di nt h ed e l e t e da r e a . .A l l
of these miRNAs have a common primary target gene,
HMGA2, as scored by Target Scan (http://www.targets-
can.org/) and miRBase (http://www.mirbase.org/), indi-
cating that they all function as repressors of this gene.
The deletion is flanked by some short segmental dupli-
cations. These, however, do not lie at the breakpoints
but further up-/downstream and thus it is unclear
whether the rearrangement could initially have been due
to non-allelic homologous recombination (NAHR).
Almost all patients published so far have been
reported to have dysmorphic facial features. However,
no unique facial gestalt does emerge. All three patients
described here had similar mild dysmorphic features:
downward slanting palpebral fissures, high bridged
narrow nose with small nares, deep grooved long phil-
trum, tented and thin upper lip, ears with broad helices
and uplifted lobuli. In addition patients 1 and 3 have
small toenails.When compared with the previous
reports, only the patient reported by Olivieri et al.
(2003) has facial features closely resembling those of our
patients [8].
A significant common feature in our three patients is
incessant middle ear and upper respiratory tract infec-
tions. No major immunological deficiency, however, was
found to cause the vicious circle of infections, and in
the father this symptom disappeared at his teens. Only
three previously reported patients suffered from recur-
rent respiratory infections [14,15,21]. Interestingly, the
region deleted in our patients includes the gene Spleen
Tyrosine Kinase (SYK) (MIM *600085) which is widely
expressed in hematopoietic cells and other cells of
epithelial origin. SYK plays an important role in regula-
tion of innate immunity and inflammatory response,
and is involved in several human diseases such as
allergy, autoimmunity, and haematological malignancies
(reviewed by Mócsai et.al [22]). The infections seen in
our patients could be linked to reduced SYK activity and
thereby reduced, albeit not lacking, ability to activate the
inflammatory response. Recent studies in mice show
that a SYK-deletion reduces their antibacterial host
defence [23]. SYK is deleted in the patients with recur-
rent respiratory infections reported by Pfeiffer et al., and
Figure 5 Overlapping deletions at 9q22 The figure depicts the genomic segment deleted in the patients of this study, as displayed in the
UCSC Genome Browser (http://genome.ucsc.edu). Reported deletions of 9q22 that overlap the deletion found in this study are marked by black
bars; a) Redon et al. [7], patients 1 and 2, b) Shimojima et al. [5], c.1) Fujii et al. [16] patient G5, c.2) Fujii et al. [16] patient G10, d) Nowakowska et
al. [17], e) de Ravel et al. [14], f) Boonen et al. [15], g) Kosaki et al. [28]. Arrows on the black bar indicate that the deletion starts or ends outside
the area shown in the picture.
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Page 11 of 14Boonen et al. but not de Ravel et al. [14,15,21]. The
relevance of its haploinsufficiency to human recurrent
early-age upper airway infections might be a subject for
further studies.
Mental retardation among the reported 9q22 deletion
patients is common and usually moderate to severe.
Only the 4-year-old patient of Shimojima et al. with a
2,3 Mb deletion is reported to have normal development
[5]. The intelligence of the father in our family is within
normal limits although a formal neuropsychological test-
ing has not been performed. Instead, his two daughters
carrying a similar deletion are moderately retarded. In
genetic counseling a similar deletion found both in
patients with mental retardation and in a family member
with normal cognitive function understandably poses
difficulties. The cause of the variable expression remains
to be found. According to the Database of Genomic
Variants (http://projects.tcag.ca/variation) the deletion
described here has not been found in healthy controls.
Reduced penetrance was not found to be due to mosai-
cism admitting the fact that in addition to lymphocytes
no other tissue like semen or buccal cells were exam-
ined. The parents did not consider further studies for
mosaicism important and thus it was not pursued.
Another explanation for variable expression would be
two simultaneous genomic hits acting either indepen-
dently or by affecting the same signaling pathway [24].
In our family the first hit would be the deletion, but the
second hit would need other methods to be detected.
The paternal microdeletion could also reveal a maternal
allelic recessive defect and the consequent autosomal
compound heterozygosity in the two daughters would
be the cause of their cognitive impairment. No obvious
candidate gene is situated in the deleted region. Micro-
deletions are increasingly frequently encountered asso-
ciated with the phenomenon of variable penetrance and
even nonpenetrance, 15q13.3 microdeletion syndrome
being one example [25]. The deleted region is not
k n o w nt ob ea f f e c t e db yi m p r i n t i n gt h a tc o u l dc a u s e
cognitive differences among the patients.
A common developmental problem of our three
patients is dysarthria, which is severe and making even
the speech of the cognitively normal father difficult to
comprehend. A similar problem has not been described
in the previously published patients and further studies
are needed to explore whether a locus for dysarthria
resides in the region defined by the deletion.
Both daughters in our family had symptoms suspected
to be epileptic although the diagnosis could not be con-
firmed. Eight patients from the literature suffer from
epilepsy, but no characteristic seizure type emerged [1,
7, 10, 26 (two patients), 16 (two patients), 27].
P a t i e n t3h a du n i l a t e r a lh y p o p l a s t i ck i d n e ya n dv e s i -
coureteral reflux. Also three previous patients had a
renal problem; hydronephrosis, renal dysplasia or hydro-
ureter [10,16,28]. Interestingly, patient 3 had a congeni-
tal chest deformity similar to one of the diagnostic
criteria of NBCCS [29]. Additional X-rays could have
clarified the presence of possible other NBCCS related
skeletal signs. The 9q22 deletion detected did not, how-
ever, include PTCH1 gene and since our patient other-
wise had no indications for further X-ray examinations,
it was considered clinically inappropriate to take them.
The patient’s chest deformity can be independent of the
deletion since patients 1 and 2 do not have thoracic
anomalies. Yet, one is tempted to speculate that it is a
sign that the deletion might effect the expression of
PTCH1.
Another clinically important gene included in the
deletion is ROR2. Gain of function mutations of one
allele are known to cause brachydactyly type B1 while a
mutation of both alleles cause Robinow Syndrome
[30,31]. However, haploinsufficiency of ROR2 has no
effect on phenotype as shown by Oldridge et al., who
described two unrelated patients with de novo deletions
at 9q22 [30]. Accordingly, none of the six previous
patients, nor our patients, whose deletion includes
ROR2, have either brachydactyly type B1 or features of
Robinow Syndrome [[3]3 (restudied in 15), [8,15-17]]
(Table 1).
Shimojima et al. suggested that del 9q22 might be a
novel overgrowth syndrome byp a t e r n a li m p r i n t i n g[ 5 ] .
Among the previous patients eight carry a deletion in
the paternally inherited chromosome [[3] (patient 1),
[5,7] (patients 1 and 2), [8,28]] and three are maternally
deleted [[3] (patient 2), [9,10]]. These small numbers are
naturally liable to bias. Indeed, the paternally deleted
patients seem to have a large neonatal size. Among
those with data on postnatal growth 3/5 are mildly tall
and 4/6 have macrocephaly. Growth data of the three
maternally deleted patients is scanty but none of them
seems to be tall or to have macrocephaly. The maternal
deletions reported appear to be much larger which
implies a more significant genomic imbalance and could
alone explain differences in phenotype (Table 1).
Recently Kosaki et al. [28] narrowed the region of the
proposed overgrowth factor closer to PTCH1 gene by
their patient’s deletion in relation to that of the patients
published by Shimojima et al. and Redon et al. [5,7].
Our family’s deletion helps to bring it even closer to
PTCH1. On the other hand tallness and macrocephaly
are also inherent features of NBCCS [32]. In a thorough
survey of a large series of NBCCS patients Kimonis et
al. observed no imprinting effect regarding any feature
of the syndrome including macrocephaly [29]. Over-
growth like macrocephaly observed in del 9q22 patients
could thus simply reflect the simultaneous haploinsuffi-
ciency of PTCH1.
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include both parental samples in array molecular karyo-
typing. In a more usual situation with only one develop-
mentally retarded child in the family one might for
several reasons be tempted to accept the analysis of the
child alone or with only one parent and unknowingly
thus get misleading information of the situation. Micro-
deletion 9q22 adds to the increasing number genomic
imbalances that challenge genetic counseling.
Conclusions
In conclusion, 9q22 deletions are rare and both pheno-
typically and molecularly unique. In the majority the
deletion contains the PTCH1 gene, which signifies that
the patients in addition to the common mental retarda-
tion also develop the tumor proneness syndrome of
Gorlin, which is to be taken into account in counseling
and follow-up. We present the first familial 9q22 dele-
tion, a father and his two developmentally delayed
daughters. Their deletion leaves the PTCH1 gene intact.
The father does not have significant cognitive problems
but has renal and thoracic cage malformations while the
daughters do not have congenital malformations. Dys-
arthric speech and prolonged tendency to ear and upper
respiratory infections are common to all three. Major
differences in psychomotor development warrant cau-
tiousness in genetic counseling in patients with similar
deletions.
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